Dublin, 14 May 2025 – Clonmel Healthcare, the number one generic supplier of medicines by value and volume in the Irish market* has announced the appointment of Donagh O’Leary as Managing Director.
Prior to taking up this role, Donagh served as Director of Marketing and Business Development. He was recently appointed as Vice Chair of Medicines for Ireland (MFI), the pharmaceutical industry body.
In his role, he is responsible for leading the company’s strategic direction, overseeing all aspects of operations, and driving continued growth and innovation. He also focuses on strengthening relationships with key stakeholders, including healthcare professionals, pharmacies, and regulatory bodies.
Bringing over twenty five years’ experience in the pharmaceutical and healthcare industries to the role, he previously held senior positions in Eco Biotechnics Distributors and Mundipharma Pharmaceuticals. He has a proven track record of success in driving commercial growth and managing complex supply chains. He holds a Master’s degree in Business from Maynooth University and Post Graduate Sustainability Leadership in Business from Technological University Dublin.
Donagh O’Leary said: “Clonmel Healthcare has a strong reputation for providing essential healthcare products to the Irish market, and I’m thrilled to continue collaborating with our exceptional team, building upon this foundation of success. Our unwavering commitment remains: ensuring the right medicine reaches the right patient at the right time, empowering individuals across Ireland to proactively manage their health and wellbeing with dignity and caring for people’s health as a trusted partner.”
Clonmel Healthcare has a long and proud history of serving the Irish community, offering a wide range of over-the-counter medicines, prescription pharmaceuticals, and innovative speciality medication solutions in areas such as Parkinsons Disease and Biosimilars.
For further information, visit: www.clonmelhealthcare.ie
* IQVIA IRLP UN/MAT/MAR/24 and EUR/MAT/MAR/24
Read our Latest News HERE
